FFA
GNOM icon

Founders Financial Alliance’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Founders Financial Alliance’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Buy
+443
New +$20.5K ﹤0.01% 580
2025
Q4 		– Sell
-531
Closed -$20.6K – 651
2025
Q3 		$20.6K Buy
+531
New +$19.2K ﹤0.01% 561
2025
Q1 		– Sell
-536
Closed -$20.8K – 628
2024
Q4 		$20.8K Sell
536
-75
-12% -$3.15K 0.01% 439
2024
Q3 		$27.5K Sell
611
-6
-1% -$268 0.01% 432
2024
Q2 		$25.8K Sell
617
-31
-5% -$1.3K 0.01% 422
2024
Q1 		$29.5K Hold
648
– – 0.01% 416
2023
Q4 		$30K Hold
648
– – 0.01% 375
2023
Q3 		$26.4K Hold
648
– – 0.01% 365
2023
Q2 		$31.4K Sell
648
-43
-6% -$2.15K 0.01% 380
2023
Q1 		$34.5K Sell
691
-1
-0.1% -$51 0.02% 332
2022
Q4 		$35K Hold
692
– – 0.02% 354
2022
Q3 		$35K Buy
+692
New +$39K 0.02% 346
2022
Q2 		– Sell
-842
Closed -$51K – 520
2022
Q1 		$51K Sell
842
-94
-10% -$5.93K 0.02% 321
2021
Q4 		$74K Hold
936
– – 0.03% 323
2021
Q3 		$83K Hold
936
– – 0.04% 291
2021
Q2 		$93K Hold
936
– – 0.04% 301
2021
Q1 		$84K Buy
936
+395
+73% +$39K 0.04% 286
2020
Q4 		$51K Buy
541
+75
+16% +$6.28K 0.03% 293
2020
Q3 		$34K Buy
+466
New +$33.4K 0.02% 455

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Founders Financial Alliance's GNOM Position: Q1 2026 in Review

Founders Financial Alliance opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026: 443 shares worth $19.4K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings. This is a return to the name: Founders Financial Alliance previously reported a position in GNOM as recently as Q3 2025.

Founders Financial Alliance first reported a position in GNOM in Q3 2020 and has held it in 19 quarters since. The position peaked at $93K in Q2 2021. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Founders Financial Alliance held 443 shares of Global X Genomics & Biotechnology ETF worth $19.4K as of Q1 2026.
  • Global X Genomics & Biotechnology ETF was a new Founders Financial Alliance position in Q1 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Founders Financial Alliance's portfolio in Q1 2026, its #580 holding.
  • Founders Financial Alliance first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and has held it in 19 quarters since.
  • Founders Financial Alliance's Global X Genomics & Biotechnology ETF position peaked at $93K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.